Home/Filings/4/0001127602-20-031800
4//SEC Filing

Jones Michael L 4

Accession 0001127602-20-031800

CIK 0000882796other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 4:41 PM ET

Size

5.1 KB

Accession

0001127602-20-031800

Insider Transaction Report

Form 4
Period: 2020-12-15
Jones Michael L
Exec. Director, Finance - PAO
Transactions
  • Award

    Emp. Stock Option (Right to Buy)

    2020-12-15+30,00030,000 total
    Exercise: $8.31From: 2021-12-15Exp: 2030-12-15Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1
  • filerCIK 0001800060

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:41 PM ET
Size
5.1 KB